Elicera Therapeutics AB
F:8E8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
L
|
Lennar Corp
XBER:LNN
|
US |
|
Asimilar Group PLC
LSE:ASLR
|
UK |
|
A
|
Alpha Ocean Resources Bhd
KLSE:AORB
|
MY |
|
X-Terra Resources Inc
XTSX:XTT
|
CA |
|
Great Panther Mining Ltd
OTC:GPLDF
|
CA |
|
C
|
Cascada Silver Corp
CNSX:CSS
|
CA |
|
Fastly Inc
NASDAQ:FSLY
|
US |
Wall Street
Price Targets
Price Targets Summary
Elicera Therapeutics AB
According to Wall Street analysts, the average 1-year price target for Elicera Therapeutics AB is 0.657 EUR with a low forecast of 0.65 EUR and a high forecast of 0.676 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Elicera Therapeutics AB's stock price target?
Price Target
0.657
EUR
According to Wall Street analysts, the average 1-year price target for Elicera Therapeutics AB is 0.657 EUR with a low forecast of 0.65 EUR and a high forecast of 0.676 EUR.
What is Elicera Therapeutics AB's Revenue forecast?
Projected CAGR
80%
For the last 4 years the compound annual growth rate for Elicera Therapeutics AB's revenue is 1 060%. The projected CAGR for the next 3 years is 80%.
